Brief: Nordic Nanovector Q2 Comprehensive Loss Widens To NOK 110.4 Mln

Thor Medical ASA

22/08/2019 06:11

Aug 22 (Reuters) - Nordic Nanovector ASA  NANOV.OL :
    * TOTAL OPERATING EXPENSES FOR Q2 WERE NOK 111.0 MILLION
(NOK 84.5
MILLION)
    * RESEARCH AND DEVELOPMENT (PRECLINICAL, CLINICAL, MEDICAL
AFFAIRS, REGULATORY AND CMC ACTIVITIES) EXPENSES ACCOUNTED FOR
77 % OF TOTAL OPERATING EXPENSES (72.2 %) FOR FIRST HALF OF 2019
    * COMPREHENSIVE LOSS FOR Q2 AMOUNTED TO NOK 110.4 MILLION
(LOSS OF
NOK 82.9 MILLION)
    * REVENUES FOR Q2 AMOUNTED TO NOK 0.0 (NOK 0.0 MILLION)
    * CASH AND CASH EQUIVALENTS AMOUNTED TO NOK 443.5 MILLION AT
END
OF JUNE 2019

Source text for Eikon:  ID:nWkrbYgb8B 
Further company coverage:  NANOV.OL 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))